IP Library › Granted Patent US 9,610,294
Granted Patent B2
US 9,610,294 · App. 14/588,785 · Granted Apr 4, 2017

Methods and compositions for the treatment of fluid accumulation in and/or under the retina

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,610,294
App. No.
14/588,785
Granted
Apr 4, 2017
Kind
B2
Abstract

The present invention provides methods and compositions for the treatment of fluid accumulation in and/or under the retina.

Claims (3)

1. A method for the treatment of fluid accumulation in and/or under the retina in a subject who has diabetic retinopathy, the method comprising administering a biodegradable ocular implant comprising a mineralocorticoid receptor (MR) antagonist to the eye of the subject.

2. The method according to claim 1 , wherein the mineralocorticoid receptor (MR) antagonist is a spirolactone-type steroidal compound.

3. The method according to claim 2 , wherein the mineralocorticoid receptor (MR) antagonist is eplerenone.

Assignments (4)
CHANGE OF NAME Recorded May 12, 2022
From: UNIVERSITE DE PARIS
To: UNIVERSITÉ PARIS CITÉ
Reel/Frame 059988/0388 →
MERGER Recorded May 12, 2022
From: UNIVERSITE PARIS DESCARTES
To: UNIVERSITE DE PARIS
Reel/Frame 060044/0856 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 2, 2016
From: BEHAR-COHEN, FRANCINE; FARMAN, NICOLETTE; JAISSER, FREDERIC
To: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE)
Reel/Frame 037874/0047 →
JOINT OWNERSHIP ASSIGNMENT Recorded Mar 2, 2016
From: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE)
To: INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE); UNIVERSITE PARIS DESCARTES; ASSISTANCE PUBLIQUE HOPITAUX DE PARIS
Reel/Frame 037976/0497 →